V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240013700 | 240007294 | 1.51 | 58.16 | Palliative (P) | 2017-05-09 | 2017-08-31 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 240028055 | CARBOPLATIN + PACLITAXEL |
| 240013701 | 240016080 | 1.59 | 66 | Palliative (P) | 2017-02-27 | 2017-03-27 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028067 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240013702 | 240007298 | 1.73 | 68.9 | Palliative (P) | 2015-07-22 | 2015-07-22 | Carboplatin + Paclitaxel (weekly) | N | N | 240028075 | CARBOPLATIN + PACLITAXEL |
| 240013703 | 240011932 | 1.72 | 71 | Curative (C) | null | 2017-07-14 | CVP R | 2 | N | 240028082 | CVP R |
| 240013704 | 240007303 | null | 94.1 | Palliative (P) | 2014-03-04 | 2014-03-04 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240028100 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240013705 | 240011935 | 1.6 | 78 | Not known (9) | null | 2017-06-29 | Carboplatin + Paclitaxel (weekly) | Y | N | 240028113 | CARBOPLATIN + PACLITAXEL |
| 240013706 | 240007310 | 1.75 | 51 | Palliative (P) | 2017-12-25 | 2018-01-14 | CISPLATIN + RT | N | null | 240028146 | CISPLATIN + RT |
| 240013707 | 240011938 | 1.52 | 62.1 | Palliative (P) | 2018-03-01 | 2018-03-18 | CVP R | N | null | 240028155 | CVP R |
| 240013708 | 240007315 | null | 81 | Palliative (P) | 2015-07-20 | 2015-07-27 | CVP R | N | null | 240028175 | CVP R |
| 240013709 | 240007317 | null | 83.2 | Curative (C) | 2018-06-13 | 2018-06-13 | CISPLATIN + RT | 02 | N | 240028191 | CISPLATIN + RT |
| 240013710 | 240007320 | 1.54 | 72 | Curative (C) | 2017-05-10 | 2017-06-18 | Cisplatin + Radiotherapy | N | Y | 240028207 | CISPLATIN + RT |
| 240013711 | 240007322 | 1.76 | 56.7 | Curative (C) | 2015-05-31 | 2015-06-06 | Cisplatin + Radiotherapy | N | N | 240028227 | CISPLATIN + RT |
| 240013712 | 240014123 | 1.64 | 83.2 | Curative (C) | 2018-09-22 | 2018-11-15 | Cisplatin + Radiotherapy | N | Y | 240028228 | CISPLATIN + RT |
| 240013713 | 240014123 | 1.6 | 36 | Neo-adjuvant (N) | 2016-03-08 | 2016-03-30 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240028228 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240013714 | 240007325 | 1.65 | 61 | Palliative (P) | 2015-08-19 | 2015-09-07 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 240028242 | CARBOPLATIN + PACLITAXEL |
| 240013715 | 240007327 | 1.84 | 55.4 | Palliative (P) | 2018-06-22 | 2018-06-23 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 240028243 | CARBOPLATIN + PACLITAXEL |
| 240013716 | 240007331 | 1.75 | 63 | Palliative (P) | 2016-03-16 | 2016-03-26 | CARBOPLATIN + PACLITAXEL | 02 | N | 240028288 | CARBOPLATIN + PACLITAXEL |
| 240013717 | 240007333 | 1.82 | 53 | Curative (C) | null | 2016-01-04 | Cisplatin + Radiotherapy | null | Y | 240028296 | CISPLATIN + RT |
| 240013718 | 240007335 | 1.74 | 42.35 | Palliative (P) | 2016-08-07 | 2017-06-05 | Methotrexate intrathecal | 2 | N | 240028305 | METHOTREXATE INTRATHECAL |
| 240013719 | 240007337 | 1.67 | null | Palliative (P) | 2015-11-27 | 2015-11-27 | PACLITAXEL | 2 | N | 240028317 | PACLITAXEL |
| 240013720 | 240007342 | 1.72 | 67.9 | Curative (C) | 2018-06-24 | 2018-06-24 | INTERLACE TRIAL | N | N | 240028372 | INTERLACE TRIAL |
| 240013721 | 240007344 | 1.73 | 67 | Palliative (P) | null | 2018-05-19 | Trial Unspecified | Y | N | 240028374 | TRIAL |
| 240013722 | 240007346 | 1.6 | null | Curative (C) | 2015-10-02 | 2015-10-05 | CHOP | 99 | N | 240028397 | CHOP |
| 240013723 | 240007348 | null | 23.4 | Disease modification (D) | 2018-06-13 | 2018-06-17 | Bevacizumab 15mg/kg | 01 | N | 240028402 | BEVACIZUMAB |
| 240013724 | 240014130 | 1.75 | 64 | Palliative (P) | null | 2014-03-11 | null | N | N | 240028417 | NOT MATCHED |
| 240013725 | 240007351 | null | 74.2 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-10 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240028436 | NOT MATCHED |
| 240013726 | 240011954 | 1.66 | 95 | Neo-adjuvant (N) | 2015-08-30 | 2015-09-01 | Bevacizumab 15mg/kg | N | N | 240028444 | BEVACIZUMAB |
| 240013727 | 240015232 | null | null | Palliative (P) | 2016-04-16 | 2016-04-20 | Bevacizumab 15mg/kg | N | N | 240028447 | BEVACIZUMAB |
| 240013728 | 240007354 | 1.57 | 81.3 | Palliative (P) | 2017-12-04 | 2018-02-21 | Carboplatin AUC 2 - 5 | N | N | 240028453 | CARBOPLATIN |
| 240013729 | 240007356 | 0 | 71 | Palliative (P) | 2017-11-22 | 2017-11-29 | Paclitaxel 7 day | N | N | 240028463 | PACLITAXEL |
| 240013730 | 240007359 | 1.61 | 89.6 | Palliative (P) | 2015-08-01 | 2015-08-12 | Carboplatin AUC 2 - 5 | N | N | 240028481 | CARBOPLATIN |
| 240013731 | 240007362 | 0 | 88.4 | Adjuvant (A) | 2016-11-24 | 2018-04-01 | CHOP | Y | N | 240028483 | CHOP |
| 240013732 | 240007363 | 1.66 | 69.7 | Palliative (P) | 2014-06-16 | 2014-07-09 | Methotrexate intrathecal | 02 | N | 240028511 | METHOTREXATE INTRATHECAL |
| 240013733 | 240011963 | 1.53 | null | Palliative (P) | null | 2014-04-25 | Bevacizumab+Carbo+Pacliaxel | 99 | null | 240028516 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013734 | 240014133 | 1.74 | 64.3 | Adjuvant (A) | 2016-11-18 | 2017-08-02 | PACLITAXEL | 02 | null | 240028542 | PACLITAXEL |
| 240013735 | 240007367 | 1.73 | null | Curative (C) | 2016-08-31 | 2016-08-31 | Methotrexate intrathecal | 02 | null | 240028547 | METHOTREXATE INTRATHECAL |
| 240013736 | 240007370 | 1.6 | 76 | Disease modification (D) | 2018-01-20 | 2018-01-20 | Azacitidine | N | N | 240028616 | AZACITIDINE |
| 240013737 | 240007372 | 1.53 | null | Palliative (P) | 2019-07-13 | 2019-07-13 | Bevacizumab+Carbo+Pacliaxel | Y | Y | 240028623 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013738 | 240007374 | 1.7 | 62.9 | Curative (C) | 2014-10-14 | 2014-12-10 | Paclitaxel 7 day | N | N | 240028629 | PACLITAXEL |
| 240013739 | 240007375 | 1.53 | 135.3 | Palliative (P) | 2017-08-27 | 2017-09-18 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | N | 240028630 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013741 | 240007383 | 1.92 | 79.5 | Palliative (P) | 2015-04-01 | 2015-04-03 | Bevacizumab | N | N | 240028677 | BEVACIZUMAB |
| 240013742 | 240015792 | 1.73 | 62.1 | null | 2018-05-16 | 2018-05-19 | Trial Unspecified | N | N | 240028684 | TRIAL |
| 240013743 | 240007387 | 1.64 | 79.7 | Curative (C) | null | 2018-02-27 | CARFILZOMIB + Dexamethasone | N | N | 240028691 | NOT MATCHED |
| 240013744 | 240011975 | 1.89 | 29.9 | Disease modification (D) | 2016-02-29 | 2016-05-04 | Trial Unspecified | N | N | 240028705 | TRIAL |
| 240013745 | 240014138 | 1.66 | null | Palliative (P) | 2013-07-29 | 2013-08-29 | Azacitidine | N | N | 240028722 | AZACITIDINE |
| 240013746 | 240011978 | 1.71 | 51 | Disease modification (D) | 2017-02-23 | 2017-02-23 | Methotrexate intrathecal | 02 | N | 240028727 | METHOTREXATE INTRATHECAL |
| 240013747 | 240014139 | 1.69 | null | Palliative (P) | 2014-02-04 | 2014-03-14 | Carboplatin AUC 6 - 10 | N | N | 240028732 | CARBOPLATIN |
| 240013748 | 240007396 | 1.78 | 81 | Curative (C) | 2015-04-27 | 2017-03-15 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240028756 | NOT MATCHED |
| 240013749 | 240007401 | 1.58 | 79.6 | Curative (C) | null | 2017-11-17 | ETOPOSIDE + THIOTEPA | N | N | 240028786 | NOT MATCHED |
| 240013750 | 240007404 | 1.74 | 0 | Palliative (P) | 2017-07-17 | 2017-08-14 | R2W trial | null | N | 240028796 | TRIAL |